SCHEMBL2560448

SCHEMBL2560448

CN(CCN)CC(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL28684528 0.98 BHMT (0.44)
Hydrochloric Acid SCHEMBL28198076 0.98 BHMT (0.44)
SCHEMBL16913017 0.95 BHMT (0.43)
SCHEMBL3384214 0.86 CHRM2 (0.46)
SCHEMBL24112603 0.84 CHRM2 (0.56)
SCHEMBL918386 0.84 TDP1 (0.50)
SCHEMBL15393667 0.83 MVD (0.37)
SCHEMBL11213606 0.83 BHMT (0.44)
Ammonia Solution, Strong SCHEMBL27395832 0.82 CHRM2 (0.54)
SCHEMBL21048742 0.82 KMT2A (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116715828-A Water-based polyurethane-urea dispersion with enhanced hydrogen bond and ion interaction, and preparation method and application thereof 万华化学集团股份有限公司 2023-09-08 CN claimed
US-20260116923-A1 CYCLIC PEPTIDE IL-1BETA TRAP FOR THE TREATMENT OF ATHEROSCLEROSIS AND INFLAMMATORY DISORDERS MERCK SHARP & DOHME LLC (US) 2026-04-30 US disclosed
CN-116715828-A Water-based polyurethane-urea dispersion with enhanced hydrogen bond and ion interaction, and preparation method and application thereof 万华化学集团股份有限公司 2023-09-08 CN disclosed
CN-116075307-A Pyridooxazine amino derivatives as ALK5 inhibitors 奇斯药制品公司 2023-05-05 CN disclosed
CN-115279741-A 4-phenyl-N- (phenyl) thiazol-2-amine derivatives and related compounds as Aryl Hydrocarbon Receptor (AHR) agonists for the treatment of, for example, angiogenesis-related disorders or inflammatory disorders 医肯纳肿瘤学公司 2022-11-01 CN disclosed
US-20220340893-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION A/S (DK) 2022-10-27 US disclosed
US-11225655-B2 Bi-functional complexes and methods for making and using such complexes NUEVOLUTION A/S (DK) 2022-01-18 US disclosed
EP-3912982-A1 NOVEL HYDROPHILIC LINKERS AND LIGAND-DRUG CONJUGATES THEREOF Hangzhou Dac Biotech Co., Ltd (CN) 2021-11-24 EP disclosed
EP-3271329-B1 NOVEL HYDROPHILIC LINKERS AND LIGAND-DRUG CONJUGATES THEREOF HANGZHOU DAC BIOTECH CO LTD (CN) 2021-08-18 EP disclosed
US-11021444-B2 Antiviral compounds Janssen Biopharma, Inc. (US) 2021-06-01 US disclosed
WO-2018140834-A1 ZWITTERIONICALLY MODIFIED POLYMERS AND HYDROGELS CORNELL UNIVERSITY (US) 2018-08-02 WO disclosed
US-20180110876-A1 NOVEL HYDROPHILIC LINKERS AND LIGAND-DRUG CONJUGATES THEREOF HANGZHOU DAC BIOTECH CO., LTD. (CN) 2018-04-26 US disclosed
US-20180110876-A1 NOVEL HYDROPHILIC LINKERS AND LIGAND-DRUG CONJUGATES THEREOF HANGZHOU DAC BIOTECH CO., LTD. (CN) 2018-04-26 US disclosed
US-20170157303-A1 ANTI-THROMBOTIC MATERIAL TORAY INDUSTRIES, INC. (JP) 2017-06-08 US disclosed
US-20160045528-A1 COMBINATION THERAPY FOR TREATING A PARAMYXOVIRUS ALIOS BIOPHARMA, INC. 2016-02-18 US disclosed
US-20150065504-A1 ANTIVIRAL COMPOUNDS ALIOS BIOPHARMA, INC. 2015-03-05 US disclosed
US-20130281324-A1 BI-FUNCTINAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION A/S (DK) 2013-10-24 US disclosed
EP-2558577-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES Nuevolution A/S (DK) 2013-02-20 EP disclosed
WO-2011127933-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION A/S (DK) 2011-10-20 WO disclosed
EP-2266528-A1 Process for colouring and/or bleaching human hair using a composition comprising an amino trialkoxysilane or amino trialcenyloxysilane L'Oréal (FR) 2010-12-29 EP disclosed